Third‐line systemic chemotherapy for small cell lung cancer
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness and safety of third‐line chemotherapy in patients with small cell lung cancer (SCLC), compared to conventional supportive care.